No Carolina / NY / Florida
Ph: 561.316.3330

No Carolina | NY | Florida

HomeEXECUTIVES

Category: EXECUTIVES

Avation Medical adds Vice President...

“Adding Michael to the Avation leadership team is our next step in launching Vivally,” said Jill Schiaparelli, founder and CEO of Avation Medical. “Patients have been crystal clear that they want a surgical-free, non-invasive treatment option for their OAB symptoms. Our focus now is to ensure that Vivally is easily accessible to the 46 million patients suffering from OAB in this country.”

Xeno Biosciences Welcomes New CEO,...

Dennis has an extraordinary depth of knowledge and is highly respected in the obesity field; I could not imagine anyone more perfect to lead our company,” said Jeff Arnold, Chairman and a Director at Xeno Biosciences since 2017.

Avation Medical adds Vice President of Market Access

“Adding Michael to the Avation leadership team is our next step in launching Vivally,” said Jill Schiaparelli, founder and CEO of Avation Medical. “Patients have been crystal clear that they want a surgical-free, non-invasive treatment option for their OAB symptoms. Our focus now is to ensure that Vivally is easily accessible to the 46 million patients suffering from OAB in this country.”

Sean J. Shapiro Appointed Soliton Vice President of Sales Effective January 1, 2021

December 30, 2020 Sean J. Shapiro was Vice President of Commercial Operations at Viveve Inc., a Women's Health Company that manufactures patented CMRF Technology, where he recruited a sales team that generated approximately $11 million in revenue in the year of launch. Prior to this, Sean J. Shapiro served as Senior Director of the North America Device Division at Merz, where he successfully led a team of over 60 sales professionals and helped launch Cellfina, a cellulite treatment device that generated...

Cognoptix New Board of Directors Announced December 30, 2020

Cognoptix other milestone includes the Series R restart, recapitalization, and revitalization, the company named a new Board of Directors (BOD) formed under the leadership of Dr. Susanne Wilke, Ph.D., Cognoptix' new President, and CEO.

Professor Thomas Baumert, Founder of Alentis Therapeutics Receives Mémain-Pelletier, French Academy of Science

Baumert said, “It’s a great honor and a mark of recognition for my team, my colleagues and collaborators, some 50 in all. Now we are going to have to redouble our efforts, with a view to bringing our research to patients so they can truly benefit.”

Daniel Yeager Appointed New Senior V.P. of Market Development Of The Wound Pros

Daniel Yeager is a business professional with a vast amount of experience in sales, marketing, training, business development, and strategic planning.

Beyeonics Surgical Notes Dr. Sharon Bakalash Appointed CMO Effective October 1, 2020

Dr. Sharon Bakalsh is a seasoned biotechnology entrepreneur and an ophthalmic surgeon with more than two decades of demonstrated leadership in business, science, and medicine.

LeAnn Affholter and Carla Pagotto Join the Cardiac Insight Leadership Team: Solid and Seasoned Professionals “Jump Right In”

Employee growth comes parallel to Cardiac Insight’s Q3 record market growth. “We’re seeing tremendous market opportunity in our space, especially as cardiology steps into the spotlight amid the pandemic and physicians turn their attention to risks associated with significantly undiagnosed cardiac arrhythmias,” notes Odell. “We remain opportunistic and optimistic about the road ahead.”

Strive Health Appoints Dr. Kavita Patel to its Board of Directors: A Well-Regarded Authority Across Healthcare Sections

Dr. Patel is a primary care physician at Mary’s Center, a Federally Qualified Health Center in Washington, D.C., and a non-resident Fellow in the Department of Economic Studies at the Brookings Institution, one of the nation’s premier research and thought leadership organizations.

David McIntyre Is Appointed CFO of Tessa Therapeutics: Expert Provides 25 Years + of Global, Operational, and Legal Experience

McIntyre brings over 25 years of global financial, operational, and legal experience, including over 10 years as Chief Financial Officer of various publicly listed and privately held entities

Sean Salmon Named EVP & President Cardiovascular Portfolio Effective January 1: Continues as EVP & President Diabetes Operating Unit

Sean Salmon is a highly respected leader both inside and outside of the company, with a proven track record of building and leading high-performing teams.

By using this website you agree to accept Medical Device News Magazine Privacy Policy